Sclerosing Bone Disorders

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Seventh Edition

Volumn , Issue , 2009, Pages 411-423

  Whyte, Michael P ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889420953     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470623992.ch88     Document Type: Chapter

References (115)

1. Online Mendelian Inheritance in Man 2000 OMIM. Available online at http://www.ncbi.nlm.nih.gov/omim. Accessed September 2, 2008.
2. Castriota-Scanderbeg A, Dallapiccola B 2005 Abnormal Skeletal Phenotypes: From Simple Signs To Complex Diagnoses. Springer, New York, NY, USA.
3. Albers-Schönberg H 1904 Röntgenbilder einer seltenen, Knoch!-!enerkrankung. Meunch Med Wochenschr 51:365.
4. Whyte MP 2002 Osteopetrosis. In: Royce PM, Steinmann B (eds.) Connective Tissue and Its Heritable Disorders, 2nd ed. Wiley-Liss, New York, NY, USA, pp. 789-807.
5. Johnston CC Jr, Lavy N, Lord T, Vellios F, Merritt AD, Deiss WP Jr 1968 Osteopetrosis: A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form. Medicine (Baltimore) 47:149-167.
6. Loria-Cortes R, Quesada-Calvo E, Cordero-Chaverri E 1977 Osteopetrosis in children: A report of 26 cases. J Pediatr 91:43-17.
7. Kahler SG, Burns JA, Aylsworth AS 1984 A mild autosomal recessive form of osteopetrosis. Am J Med Genet 17:451-164.
8. Jagadha V, Halliday WC, Becker LE. Hinton D 1988 The association of infantile osteopetrosis and neuronal storage disease in two brothers. Acta Neuropathol (Berl) 75:233-240.
9. Dupuis-Girod S, Corradini N, Hadj-Rabia S, Fournet JC, Faivre L, Le Deist F, Durand P, Doffinger R, Smahi A, Israel A, Courtois G, Brousse N, Blanche S, Munnich A, Fischer A, Casanova JL, Bodemer C 2002 Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics 109:1-6.
10. Whyte MP, Wenkert D, Clements KL. McAlister WH. Mumm S 2003 Bisphosphonate-induced osteopetrosis. N Engl J Med 394:455-461.
11. Balemans W, Van Wesenbeeck L, Van Hul W 2005 A clinical and molecular overview of the human osteopetroses. Calcif Tissue Int 77:263-274.
12. Vanier V, Miller R, Carson BS 2000 Bilateral visual improvement after unilateral optic canal decompression and cranial vault expansion in a patient with osteopetrosis, narrowed optic canals, and increased intracranial pressure. J Neurol Neurosurg Psychiatry 69:405-406.
13. Waguespack SG, Hui SL, DiMeglio LA, Econs MJ 2007 Autosomal dominant osteopetrosis: Clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation. J Clin Endocrinol Metab 92:771-778.
14. Bollerslev J 1989 Autosomal dominant osteopetrosis: Bone metabolism and epidemiological, clinical and hormonal aspects. Endoer Rev 10:45-67.
15. Resnick D, Niwayama G 2002 Diagnosis of Bone and Joint Disorders, 4th ed. Saunders, Philadelphia, PA, USA.
16. Di Rocco M, Buoncompagni A. Loy A, Dellacqua A 2000 Os-teopetrorickets: Case report. Eur J Paediatr Neurol 159:579-581.
17. Rao VM, Dalinka MK, Mitchell DG, Spritzer CE, Kaplan F, August CS, Axel L, Kressel HY 1986 Osteopetrosis: MR characteristics at 1.5 T. Radiology 161:217-220.
18. Elster AD, Theros EG, Key LL, Chen MYM 1992 Cranial imaging in autosomal recessive osteopetrosis (parts I & II). Radiology 183:129-144.
19. Key LL, Carnes D. Cole S, Holtrop M, Bar-Shavit Z, Shapiro F. Arceci R, Steinberg J, Gundberg C, Kahn A, Teitelbaum S, Anast C 1984 Treatment of congenital osteopetrosis with high dose calcitriol. N Engl J Med 310:409-415.
20. Whyte MP, Chines A. Silva DP Jr, Landt Y, Ladenson JH 1996 Creatine kinase brain isoenzyme (BB-CK) presence in serum distinguishes osteopetrosis among the sclerosing bone disorders. J Bone Miner Res 11:1438-1443.
21. Alatalo SL, Ivaska KK, Waguespack SG, Econs MJ, Vaananen HK, Halleen JM 2004 Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in AlbersSchönberg disease (type II autosomal dominant osteopetrosis). Clin Chem 50:883-890.
22. Sobacchi C, Frattini A, Guerrini MM, Abinun M, Pangrazio A, Susani L, Bredius R, Mancini G, Cant A, Bishop N, Grabowski P, Del Fattore A, Messina C, Errigo G, Coxon FP, Scott DI, Teti A, Rogers MJ, Vezzoni P, Villa A, Helfrich MH 2007 Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat Genet 39:960-962.
23. Helfrich MH, Aronson DC, Everts V, Mieremet RHP, Gerritsen EJA. Eckhardt PG, Groot CG, Scherft JP 1991 Morphologic features of bone in human osteopetrosis. Bone 12:411-419.
24. Bollerslev J, Steiniche T, Meisen F, Mosekilde L 1986 Structural and histomorphometric studies of iliac crest trabecular and cortical bone in auto somal dominant osteopetrosis: A study of two radiological types. Bone 10:19-24.
25. Lajeunesse D, Busqué L, Ménard P, Brunette MG, Bonny Y 1996 Demonstration of an osteoblast defect in two cases of human malignant osteopetrosis. Correction of the phenotype after bone marrow transplant. Bone 98:1835-1842.
26. Mills BG, Yabe H, Singer FR 1988 Osteoclasts in human osteopetrosis contain viralnucleocapsid-like nuclear inclusions. J Bone Miner Res 3:101-106.
27. Beard CI, Key L, Newburger PE, Ezekowitz RA, Arceci R, Miller B. Proto P, Ryan T, Anast C, Simons ER 1986 Neutrophil defect associated with malignant infantile osteopetrosis. J Lab Clin Med 108:498-505.
28. Cleiren E, Benichou O, Van Hul E, Gram J, Bollerslev J, Singer FR, Beaverson K, Aledo A, Whyte MP, Yoneyama T, deVerne-joul MC. Van Hul W 2001 Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the CICN7 chloride channel gene. Hum Mol Genet 10:2861-2867.
29. Susani L, Pangrazio A, Sobacchi C, Taranta A, Mortier G, Sa-varirayan R, Villa A, Orchard P, Vezzoni P, Albertini A, Frattini A, Pagani F 2004 TCIRG1-dependent recessive osteopetrosis: Mutation analysis, functional identification of the splicing defects, and in vitro rescue by Ul snRNA. Hum Mutat 24:225-235.
30. Campos-Xavier AB, Saraiva JM, Ribeiro LM, Munnich A, Cormier-Daire V 2003 Chloride channel 7 (CLCN7) gene mutations in intermediate autosomal recessive osteopetrosis. Hum Genet 112:186-189.
31. Chalhoub N. Benachenhou N, Rajapurohitam V, Pata M, Ferron M, Frattini A, Villa A, Vacher J 2003 Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human. Nat Med 9:399-106.
32. Driessen GJ, Gerritsen EJ, Fischer A, Fasth A, Hop WC, Veys P, Porta F, Cant A, Steward CG, Vossen JM, Uckan D, Friedrich W 2003 Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: An EBMT report. Bone Marrow Transplant 32:657-663.
33. Rawlinson PS, Green RH, Coggins AM, Boyle IT, Gibson BE 1991 Malignant osteopetrosis: Hypercalcaemia after bone marrow transplantation. Arch Dis Child 66:638-639.
34. Steward CG. Pellier I, Mahajan A, Ashworth MT, Stuart AG, Fasth A. Lang D, Fischer A, Friedrich W, Schulz AS 2004 The Working Party on Inborn Errors of the European Blood and Marrow Transplantation Group. Severe pulmonary hypertension: A frequent complication of stem cell transplantation for malignant infantile osteopetrosis. Br J Haematol 124:63-71.
35. Tsuji Y, Ito S, Isoda T, Kajiwara M, Nagasawa M, Morio T, Mizutani S 2005 Successful nonmyeloablative cord blood transplantation for an infant with malignant infantile osteopetrosis. J Pediatr Hematol Oncol 27:495-198.
36. Key LL Jr 1987 Osteopetrosis: A genetic window into osteoclast function. Cases Metab Bone Dis. A CPC Series. Triclinica Communications. New York, NY, USA, 2:1-12.
37. Dorantes LM, Mejia AM, Dorantes S 1986 Juvenile osteopetrosis: Effects of blood and bone of prednisone and low calcium, high phosphate diet. Arch Dis Child 61:666-670.
38. Iacobini M, Migliaccio S, Roggini M, Taranta A, Werner B, Pan-ero A, Teti A 2001 Case Report: Apparent cure of a newborn with malignant osteopetrosis using prednisone therapy. J Bone Miner Res 16:2356-2360.
39. Dozier TS, Duncan IM, Klein AJ, Lambert PR, Key LL Jr 2005 Otologic manifestations of malignant osteopetrosis. Otol Neu-rotol 26:762-766.
40. Strickland JP, Berry DJ 2005 Total joint arthroplasty in patients with osteopetrosis: A report of 5 cases and review of the literature. J Arthoplasty 20:815-820.
41. Sly WS, Hewett-Emmett D, Whyte MP, Yu YS, Tashian RE 1983 Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci USA 80:2752-2756.
42. Whyte MP 1993 Carbonic anhydrase II deficiency. Clin Orthop 294:52-63.
43. Sly WS, Shah GN 2001 The carbonic anhydrase II deficiency syndrome: Osteopetrosis with renal tubular acidosis and cerebral calcification. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Child B, Vogelstein B (eds.) The Metabolic and Molecular Bases of Inherited Disease, 8th ed. McGraw-Hill Book Company. New York, NY, USA, pp. 5331-5343.
44. Roth DE, Venta PJ, Tashian RE, Sly WS 1992 Molecular basis of human carbonic anhydrase II deficiency. Proc Natl Acad Sci USA 89:1804-1808.
45. Shah GN, Bonapace G, Hu PY, Strisciuglio P, Sly WS 2004 Carbonic anhydrase II deficiency syndrome (osteopetrosis with renal tubular acidosis and brain calcification): Novel mutations in CA2 identified by direct sequencing expand the opportunity for geno-type-phenotype correlation. Hum Mutat 24:272.
46. Whyte MP, Hamm LL III, Sly WS 1988 Transfusion of carbonic anhydrase-replete erythrocytes fails to correct the acidification defect in the syndrome of osteopetrosis, renal tubular acidosis, and cerebral calcification (carbonic anhydrase II deficiency). J Bone Miner Res 3:385-388.
47. McMahon C, Will A, Hu P, Shah GN, Sly WS, Smith OP 2001 Bone marrow transplantation corrects osteopetrosis in the carbonic anhydrase II deficiency syndrome. Blood 97:1947-1950.
48. Maroteaux P, Lamy M 1965 The malady of Toulouse-Lautrec. JAMA 191:715-717.
49. Maroteaux P, Lamy M 1962 La pycnodysostose. Presse Med 70:999-1002.
50. Gelb BD, Bromme D, Desnick RJ 2001 Pycnodysostosis: Cathep-sin K deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Child B, Vogelstein B (eds.) The Metabolic and Molecular Bases of Inherited Disease, 8th ed. McGraw-Hill Book Company, New York, NY, USA, pp. 3453-3468.
51. Elmore SM 1967 Pycnodysostosis: A review. J Bone Joint Surg Am 49:153-162.
52. Soto TJ, Mautalen CA, Hojman D, Codevilla A, Piqué J, Pangaro J A 1969 Pycnodysostosis, metabolic and histologic studies. Birth Defects 5:109-115.
53. Everts V, Aronson DC, Beertsen W 1985 Phagocytosis of bone collagen by osteoclasts in two cases of pycnodysostosis. Calcif Tissue Int 37:25-31.
54. Beneton MNC, Harris S, Kanis JA 1987 Paramyxovirus-like inclusions in two cases of pycnodysostosis. Bone 8:211-217.
55. Soliman AT, Rajab A, AlSalmi I, Darwish A, Asfour M 1996 Defective growth hormone secretion in children with pycnodysostosis and improved linear growth after growth hormone treatment. Arch Dis Child 75:242-244.
56. Fratzl-Zelman N, Valenta A, Roschger P, Nader A, Gelb BD, Fratzl P, Klaushofer K 2004 Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis. J Clin Endocrinol Metab 89:1538-1547.
57. Everts V, Hou WS, Rialland X, Tigchelaar W, Saftig P, Bromme D, Gelb BD, Beertsen W 2003 Cathepsin K deficiency in pycnodysostosis results in accumulation of non-digested phagocytosed collagen in fibroblasts. Calcif Tissue Int 73:380-386.
58. Edelson JG, Obad S, Geiger R, On A, Artul HJ 1992 Pycnodysostosis: Orthopedic aspects, with a description of 14 new cases. Clin Orthop 280:263-276.
59. Engelmann G 1929 Ein fall von osteopathia hyperostotica (sclerotisans) multiplex infantilis. Fortschr Geb Roentgen 39:1101-1106.
60. Saito T, Kinoshita A, Yoshiura KI, Makita Y, Wakui K, Honke K, Niikawa N, Taniguchi N 2001 Domain-specific mutations of a transforming growth factor (TGF)-f31 latency-associated peptide cause Camurati-Engelmann disease because of the formation of a constitutively active form of TGF-f31. J Biol Chem 276:11469-11472.
61. Wallace SE, Lachman RS, Mekikian PB, Bui KK, Wilcox WR 2004 Marked phenotypic variability in progressive diaphyseal dysplasia (Camurati-Engelmann disease): Report of a four-generation pedigree, identification of a mutation in TGFB1, and review. Am J Med Genet A 129:235-247.
62. Naveh Y, Ludatshcer R, Alon U, Sharf B 1985 Muscle involvement in progressive diaphyseal dysplasia. Pediatrics 76:944-949.
63. Crisp AJ, Brenton DP 1982 Engelmann's disease of bone: A systemic disorder? Ann Rheum Dis 41:183-188.
64. Smith R, Walton RJ, Corner BD, Gordon IR 1977 Clinical and biochemical studies in Engelmann's disease (progressive diaphyseal dysplasia). Q J Med 46:273-294.
65. Kumar B, Murphy WA, Whyte MP 1981 Progressive diaphyseal dysplasia (Englemann's disease): Scintigraphic-radiologic-clinical correlations. Radiology 140:87-92.
66. Applegate LJ, Applegate GR, Kemp SS 1991 MR of multiple cranial neuropathies in a patient with Camurati-Engelmann disease: Case report. Am Soc Neuroradiol 12:557-559.
67. Janssens K, ten Dijke P, Ralston SH, Bergmann C, Van Hul W 2003 Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J Biol Chem 278:7718-7724.
68. Saraiva JM 2000 Anticipation in progressive diaphyseal dysplasia. J Med Genet 37:394-395.
69. Hecht JT, Blanton SH, Broussard S, Scott A, Hall CR, Mlunsky JM 2001 Evidence for locus heterogeneity in the Camurati-Engelmann (DPD1) Syndrome. Clin Genet 59:198-200.
70. Naveh Y. Alon U, Kaftori JK, Berant M 1985 Progressive diaphyseal dysplasia: Evaluation of corticosteroid therapy. Pediatrics 75:321-323.
71. Inaoka T, Shuke N, Sato J, Ishikawa Y, Takahashi K, Aburano T, Makita Y 2001 Scintigraphic evaluation of Pamidronate and corticosteroid therapy in a patient with progressive diaphyseal dysplasia (Camurati-Engelmann disease). Clin Nucl Med 26:680-682.
72. Van Büchern FSP, Prick JJG, Jaspar HHJ 1976 Hyperostosis Corticalis Generalisata Familiaris (Van Buchem's Disease). Excerpta, Amsterdam, The Netherlands.
73. Perez-Vicente JA, Rodriguez de Castro E, Lafuente J, Mateo MM, Gimenez-Roldan S 1987 Autosomal dominant endosteal hyperostosis. Report of a Spanish family with neurological involvement. Clin Genet 31:161-169.
74. Beighton P, Barnard A, Hamersma H, van der Wouden A 1984 The syndromic status of sclerosteosis and van Buchem disease. Clin Genet 25:175-181.
75. Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu Y, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan J 2001 Bone dysplasia sclerosteosis results from loss of the SÖST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68:577-589.
76. Loots GG, Kneissel M, Keller H, Baptist M, Chang J, Collette NM, Ovcharenko D, Plajzer-Frick I, Rubin EM 2005 Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease. Genome Res 15:928-935.
77. Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, Wu D 2005 Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 280:19883-19887.
78. Sutherland MK, Geoghegan JC, Yu C, Turcott E, Skonier JE, Winkler DG, Latham JA 2004 Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation. Bone 35:828-835.
79. Ruckert EW, Caudill RJ, McCready PJ 1985 Surgical treatment of van Buchem disease. J Oral Maxillofac Surg 43:801-805.
80. Schendel SA 1988 van Buchem disease: Surgical treatment of the mandible. Ann Plast Surg 20:462-467.
81. Hamersma H, Gardner J, Beighton P 2003 The natural history of sclerosteosis. Clin Genet 63:192-197.
82. Beighton P, Cremin BJ, Hamersma H 1976 The radiology of sclerosteosis. Br J Radiol 49:934-939.
83. Hill SC, Stein SA, Dwyer A, Altman J, Dorwart R, Doppman J 1986 Cranial CT findings in sclerosteosis. AJNR Am J Neurora-diol 7:505-511.
84. Stein SA, Witkop C, Hill S, Fallon MD, Viernstein L, Gucer G, McKeever P, Long D, Altman J, Miller NR, Teitelbaum SL, Schlesinger S 1983 Sclerosteosis, neurogenetic and pathophysiologic analysis of an American kinship. Neurology 33:267-277.
85. Epstein S, Hamersma H, Beighton P 1979 Endocrine function in sclerosteosis. S Afr Med J 55:1105-1110.
86. Uitto J, Santa Cruz DJ, Starcher BC, Whyte MP, Murphy WA 1981 Biochemical and ultrastructural demonstration of elastin accumulation in the skin of the BuschkeOllendorff syndrome. J Invest Dermatol 76:284-287.
87. Hellemans J, Preobrazhenska O, Willaert A, Debeer P, Verdonk PC, Costa T, Janssens K, Menten B, Van Roy N, Vermeulen SJ, Savarirayan R, Van Hul W, Vanhoenacker F, Huylebroeck D, De Paepe A, Naeyaert JM, Vandesompele J, Speleman F. Ver-schueren K, Coucke PJ, Mortier GR 2004 Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis. Nat Genet 36:1213-1218.
88. Whyte MP, Murphy WA, Seigel BA 1978 99m Tc-pyrophosphate bone imaging in osteopoikilosis, osteopathia striata, and melorheostosis. Radiology 127:439-143.
89. Rabinow M, Unger F 1984 Syndrome of osteopathia striata, mac-rocephaly, and cranial sclerosis. Am J Dis Child 138:821-823.
90. Happle R, Lenz W 1977 Striation of bones in focal dermal hypoplasia: Manifestation of functional mosaicism? Br J Dermatol 96:133-138.
91. Viot G, Lacombe D, David A, Mathieu M, de Broca A, Faivre L, Gigarel N, Munnich A, Lyonnet S, Le Merrer M, Cormier-Daire V 2002 Osteopathia striata cranial sclerosis: Non-random X-inactivation suggestive of X-linked dominant inheritance. Am J Med Genet 107:1-4.
92. Campbell CJ, Papademetriou T, Bonfiglio M 1968 Melorheostosis: A report of the clinical, roentgenographic, and pathological findings in fourteen cases. J Bone Joint Surg Am 50:1281-1304.
93. Leri A, Joanny J 1922 Une affection non decrite des os. Hyperostose "en coulee" sur toute la longueur d'un membre ou "melorheostose." Bull Mem Soc Med Hop Paris 46:1141-1145.
94. Applebaum RE, Caniano DA, Sun CC, Azizkhan RA, Queral LA 1986 Synchronous left subclavian and axillary artery aneurysms associated with melorheostosis. Surgery 99:249-253.
95. Colavita N, Nicolais S, Orazi C, Falappa PG 1987 Melorheostosis: Presentation of a case followed up for 24 years. Arch Orthop Trauma Surg 106:123-125.
96. Wagers LT, Young AW Jr, Ryan SF 1972 Linear melorheostotic scleroderma. Br J Dermatol 86:297-301.
97. Kim JE, Kim EH, Han EH, Park RW, Park IH, Jun SH, Kim JC, Young MF, Kim IS 2000 A TGF-3-inducible cell adhesion mo-leculae, Big-h3, is downregulated in melorheostosis and involved in oseogeneis. J Cell Biochem 77:169-178.
98. Mumm S, Zhang X, McAlister WH, Wenkert D, Whyte MP 2005 Deactivating germline mutations in LEMD3 cause osteopoikilosis and Buschke-Ollendorff syndrome, but not melorheostosi. J Bone Miner Res 20:S1:S418.
99. Atar D, Lehman WB, Grant AD, Strongwater AM 1992 The Ilizarov apparatus for treatment of melorheostosis: Case report and review of the literature. Clin Orthop 281:163-167.
100. Christmann D, Wenger JJ, Dosch JC, Schraub M, Wackenheim A 1981 L'osteomalacie axiale: Analyse compare avec la fibrogen-ese imparfaite. J Radiol 62:37-11.
101. Whyte MP, Fallon MD, Murphy WA, Teitelbaum SL 1981 Axial osteomalacia: Clinical, laboratory and genetic investigation of an affected mother and son. Am J Med 71:1041-1049.
102. Nelson AM, Riggs BL. Jowsey JO 1978 Atypical axial osteomalacia: Report of four cases with two having features of ankylosing spondylitis. Arthritis Rheum 21:715-722.
103. Cortet B. Berniere L, Solau-Gervais E, Hacene A, Cotton A, Delcambre B 2000 Axial osteomalacia with sacroiliitis and moderate phosphate diabetes: Report of a case. Clin Exp Rheumatol 18:625-628.
104. Condon JR, Nassim JR 1971 Axial osteomalacia. Postgrad Med 47:817-820.
105. Lang R, Vignery AM, Jenson PS 1986 Fibrogenesis imperfecta ossium with early onset: Observations after 20 years of illness. Bone 7:237-246.
106. Ralphs JR, Stamp TCB, Dopping-Hepenstal PJC, Ali SY 1989 Ultrastructural features of the osteoid of patients with fibrogenesis imperfecta ossium. Bone 10:243-249.
107. Rimoin DL 1965 Pachydermoperiostosis (idiopathic clubbing and pcriostosis). Genetic and physiologic considerations. N Engl J Med 272:923-931.
108. Matucci-Cerinic M, Lott T, Jajic IVO, Pignone A, Bussani C, Cagnoni M 1991 The clinical spectrum of pachydermoperiostosis (primary hypertrophic osteoarthropathy). Medicine 79:208-214.
109. Ali A, Tetalman M, Fordham EW 1980 Distribution of hypertrophic pulmonary osteoarthropathy. AJR Am J Roentgenol 134:771-780.
110. Lauter SA. Vasey FB, Huttner I, Osterland CK 1978 Pachydermoperiostosis: Studies on the synovium. J Rheumatol 5:85-95.
111. Cooper RG, Freemont AJ, Riley M, Holt PJL, Anderson DC, Jayson MIV 1992 Bone abnormalities and severe arthritis in pachydermoperiostosis. Ann Rheum Dis 51:416-119.
112. Whyte MP, Teitelbaum SL, Reinus WR 1996 Doubling skeletal mass during adult life: The syndrome of diffuse osteosclerosis after intravenous drug abuse. J Bone Miner Res 11:554-558.
113. Khosla S, Ballard FJ, Conover CA 2002 Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis. J Clin Endocrinol Metab 87:3867-3870.
114. Boyden LM. Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP 2002 High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 345:1513-1521.
115. Rickels MR, Zhang X, Mumm S, Whyte MP 2005 Oropharyngeal skeletal disease accompanying high bone mass and novel LRP5 mutation. J Bone Miner Res 20:878-885.